Skip to main content
Clinical Trials/NCT03441022
NCT03441022
Withdrawn
N/A

Continuous Data Collection and Analysis for Stroke Prevention Using a Wearable Sensor

Mayo Clinic0 sitesJuly 15, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Mayo Clinic
Primary Endpoint
Watch Accuracy compared to BodyGuardian
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to determine whether a wristband that detects your pulse can detect your heart rate and rhythm similar to electrocardiograms (ECG).

Detailed Description

The purpose of this study is to determine whether a wristband that detects your pulse can detect your heart rate and rhythm similar to electrocardiograms (ECG). These wristbands detect your pulse based on a technique called "photoplethysmography," (PPG). PPG is a common method in which an individual's pulse is detected based on a light signature interpreted by the wristband. Most commercially available heart rate monitors use PPG to determine your heart rate, but the accuracy is variable.

Registry
clinicaltrials.gov
Start Date
July 15, 2021
End Date
August 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Suraj Kapa

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Male or female 18 years of age or older with a primary diagnosis of atrial fibrillation
  • Willing and able to provide informed consent and follow the study protocol
  • Clinically indicated planned restoration of normal rhythm

Exclusion Criteria

  • Unable to provide informed consent
  • Unable to follow the study protocol
  • Women who are pregnant
  • Subjects with implantable devices (only if participating in phase 2-BodyGuardian processes/testing)

Outcomes

Primary Outcomes

Watch Accuracy compared to BodyGuardian

Time Frame: 30 days

Determine the accuracy of ambulatory photoplethysmography for detection of heart rhythm when compared with a wearable clinically available 30 day monitor (BodyGuardian) in terms of accuracy of AF detection.

Watch Accuracy during Cardioversion

Time Frame: Duration of cardioversion procedure

Determine whether the R-R interval estimate from artifact-free non-invasive photoplethysmography sample waveform segments is a reasonable basis for a atrial fibrillation (AF) detection algorithm as compared to a gold standard measurement from ECG in the acute cardioversion setting

Similar Trials